Sanofi: Neoplasms trials
The registry lists 77 Neoplasms studies with Sanofi as lead sponsor. 0 are open to participants now and 13 have results posted.
Phase 1 55Phase 2 18Phase 3 6Phase 4 3No phase 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Study of SAR444881 Administered Alone and in Combination With Other Therapeutics in Participants With Advanced Solid TumorsTerminatedNCT04717375Phase 1/2Results posted
- Safety, Preliminary Efficacy and PK of Isatuximab (SAR650984) Alone or in Combination With Atezolizumab in Patients With Advanced MalignanciesTerminatedNCT03637764Phase 1/2Results posted
- Open Label Treatment Extension Study With SAR245408 or SAR245409 as a Monotherapy or as a Combination RegimenCompletedNCT01587040Phase 1/2Results posted
- Dose-Escalation, Safety, Pharmacokinetics Study of Cabazitaxel With Gemcitabine In Patients With Solid TumorTerminatedNCT01001221Phase 1/2Results posted
- Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic MelanomaTerminatedNCT00613509Phase 2Results posted
- Aflibercept in Combination With Docetaxel in Metastatic Androgen Independent Prostate CancerCompletedNCT00519285Phase 3Results posted
- Phase II Study of Best Support Care (BSC) Plus ZD6474(Vandetanib) in Patients With Inoperable Hepatocellular Carcinoma (HCC)CompletedNCT00508001Phase 2Results posted
- A Phase II Study of 2 Doses of ZD6474 (Vandetanib) in Combination With FOLFOX vs FOLFOX Alone for the Treatment of Colorectal CancerCompletedNCT00500292Phase 2Results posted
- XRP6258 Plus Prednisone Compared to Mitoxantrone Plus Prednisone in Hormone Refractory Metastatic Prostate CancerCompletedNCT00417079Phase 3Results posted
- Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00356122Phase 2Results posted
- Study of AVE0005 (VEGF Trap) in Patients With Chemoresistant Advanced Ovarian CancerCompletedNCT00327171Phase 2Results posted
- Study of AVE0005 (VEGF Trap) in Locally Advanced or Metastatic Platinum- and Erlotinib- Resistant Non-small-cell-lung AdenocarcinomaCompletedNCT00284141Phase 2Results posted
- Rasburicase Versus Allopurinol in Tumor Patients at Risk for Hyperuricemia and Tumor Lysis SyndromeCompletedNCT00230178Phase 3Results posted
- Dose Escalation and Expansion Study of SAR444200-based Regimen in Adult Participants With Advanced Solid TumorsTerminatedNCT05450562Phase 1/2
- Effect of Tusamitamab Ravtansine on QTc Interval in Participants With Metastatic Solid TumorsTerminatedNCT05429762Phase 1
- Comparative Efficacy of Cemiplimab to Historical Standard of Care in FranceCompletedNCT05302297
- (Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion MutationsTerminatedNCT05241873Phase 1
- (HARMONY) Study of BLU-701 in EGFR-mutant NSCLCTerminatedNCT05153408Phase 1
- Dose Escalation and Expansion Study of SAR443216 in Participants With Relapsed/Refractory HER2 Expressing Solid TumorsTerminatedNCT05013554Phase 1
- A Drug-drug Interaction Study of Avapritinib and MidazolamCompletedNCT04908176Phase 1
- (SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLCTerminatedNCT04862780Phase 1
- External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLCStatus unknownNCT04697446
- First-in-human Single Agent Study of SAR442257 in RRMM and RR-NHLTerminatedNCT04401020Phase 1
- A Study Evaluating Safety and Therapeutic Activity of THOR-707 in Adult Subjects With Advanced or Metastatic Solid Tumors (THOR-707-101)TerminatedNCT04009681Phase 1/2
- Phase 1b DV281 With an Anti-PD-1 Inhibitor in NSCLCCompletedNCT03326752Phase 1
- Evaluation of SAR408701 in Japanese Patients With Advanced Malignant Solid TumorsCompletedNCT03324113Phase 1
- A Study of SAR428926 in Patients With Advanced Solid TumorsCompletedNCT02575781Phase 1
- A Study Assessing Efficacy and Safety of SAR125844 in NSCLC Patients With MET AmplificationCompletedNCT02435121Phase 2
- Evaluation of SAR408701 in Patients With Advanced Solid TumorsTerminatedNCT02187848Phase 1
- A Safety and Efficacy Study of SAR405838 and Pimasertib in Cancer PatientsCompletedNCT01985191Phase 1
- A Study of the Safety and Pharmacokinetics of SAR245408 Tablets in Patients With Solid Tumors or LymphomaCompletedNCT01943838Phase 1
- A Phase I Study of Aflibercept Plus FOLFIRI (Irinotecan, 5-Fluorouracil, and Leucovorin) in Chinese Patients With Advanced Solid MalignanciesCompletedNCT01930552Phase 1
- A Phase I/Ib Trial for the Evaluation of SAR260301 in Monotherapy or in Combination With Vemurafenib in Patients With Various Advanced CancerCompletedNCT01673737Phase 1
- Phase I, Dose Escalation of SAR125844 in Asian Solid Tumor PatientsCompletedNCT01657214Phase 1
- Phase 1 Safety Testing of SAR405838CompletedNCT01636479Phase 1
- A Study of the Safety and Pharmacokinetics of SAR245409 Tablets in Patients With Solid Tumors or LymphomaCompletedNCT01596270Phase 1
- Pharmacokinetics and Safety Study of Cabazitaxel in Cancer Patients With Renal ImpairmentCompletedNCT01527929Phase 1
- A Dose Escalation Study of Iniparib as a Single Agent and in Combination in Solid TumorsCompletedNCT01455532Phase 1
- Safety and Pharmacokinetics of SAR245408 Daily Oral in Patients With Solid TumorsCompletedNCT01392924Phase 1
- Dose-escalation, Safety, Pharmacokinetics Study of AVE8062 Combined With Bevacizumab in Patients With Advanced Solid TumorsCompletedNCT01193595Phase 1
- First in Man Study of SAR566658 Administered in Patients With CA6-Positive and Refractory Solid TumorCompletedNCT01156870Phase 1
- A Study of Intravenous Aflibercept With Docetaxel in Chinese Patients With Solid TumorsCompletedNCT01148615Phase 1
- Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver ImpairmentCompletedNCT01140607Phase 1
- A Clinical Trial of Patients With Solid Tumours Receiving Granulocyte Colony Stimulating Factor as Primary Prophylaxis for Chemotherapy-induced Neutropenia, in a Docetaxel Based RegimenCompletedNCT01107756Phase 4
- Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Docetaxel and Cisplatin in Patients With Solid TumorsCompletedNCT01095302Phase 1
- Effect of Cabazitaxel on the QTc Interval in Cancer PatientsCompletedNCT01087021Phase 1
- A Study to Investigate the Disposition of Radio-labeled AVE8062 Compound Administered as a 30-minute IV Infusion to Patients With Advanced Solid TumorCompletedNCT01063946Phase 1
- A Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Resistant Recurrent Ovarian CancerCompletedNCT01033292Phase 2
- A Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Sensitive Recurrent Ovarian CancerCompletedNCT01033123Phase 2
- Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Cisplatin in Patients With Solid TumorsCompletedNCT01021150Phase 1
- START: Swiss Taxotere Alopecia Prevention TrialCompletedNCT01008774Not applicable
- Dose Escalation Study to Assess the Safety and Tolerability of Genz-644282 in Patients With Solid TumorsCompletedNCT00942799Phase 1
- A Study to Evaluate the Effects of Aflibercept on QTc Interval in Cancer PatientsCompletedNCT00876044Phase 1
- Safety Study of XL765 (SAR245409) in Combination With Erlotinib in Adults With Solid TumorsCompletedNCT00777699Phase 1
- Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid TumorsCompletedNCT00756847Phase 1
- AVE8062 in Combination With Platinum-taxane Doublet in Advanced Solid TumorCompletedNCT00719524Phase 1
- Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing ChemotherapyCompletedNCT00694382Phase 3
- Safety Study of XL147 (SAR245408) in Combination With Erlotinib in Adults With Solid TumorsCompletedNCT00692640Phase 1
- Larotaxel + Cisplatin Versus Gemcitabine + Cisplatin in First Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder CancerCompletedNCT00625664Phase 3
- Phase I Dose Finding Study of SSR97225 Given in Patients With Refractory CancerTerminatedNCT00547261Phase 1
- A Phase I Study of Intravenous Aflibercept in Combination With Docetaxel in Japanese Cancer PatientsCompletedNCT00545246Phase 1
- Phase I Chinese PKCompletedNCT00503711Phase 1
- Study of the Safety and Pharmacokinetics of XL147 (SAR245408) in Adults With Solid Tumors or LymphomaCompletedNCT00486135Phase 1
- Study of the Safety and Pharmacokinetics of XL765 (SAR245409) in Adults With Solid TumorsCompletedNCT00485719Phase 1
- A Phase I Study of Intravenous Aflibercept in Combination With S-1 in Japanese Cancer PatientsCompletedNCT00479076Phase 1
- Comparison of Teicoplanin and Vancomycin in Initial Empirical Antibiotic Regimen for Febrile Neutropenic PatientsCompletedNCT00454272Phase 4
- A Study Evaluating BSI-201 in Combination With Chemotherapeutic Regimens in Subjects With Advanced Solid TumorsCompletedNCT00422682Phase 1
- A Study of 1018 Immunostimulatory Sequence (ISS) Administered With Irinotecan and Cetuximab to Treat Patients With Previously Treated Metastatic Colorectal CancerTerminatedNCT00403052Phase 1
- XRP9881 in Combination With Trastuzumab in Metastatic Breast CancerCompletedNCT00386685Phase 2
- Study of XL647 Administered Orally Daily to Patients With Solid TumorsCompletedNCT00336765Phase 1
- Combination Study of a New Taxane and Capecitabine in Patients With Metastatic Breast CancerCompletedNCT00327743Phase 1/2
- Phase 1/1b Dose Escalation Study Evaluating BSI-201 as a Single Agent and in Combination With Irinotecan in Subjects With Advanced Solid TumorsCompletedNCT00298675Phase 1
- Induction Chemotherapy Comparing Taxotere® Cisplatin and 5-Fluorouracil (TPF) With Standard Cisplatin and 5-Fluorouracil (PF) Followed by Chemoradiation in Locally Advanced Head and Neck CancerCompletedNCT00273546Phase 3
- Study of Rasburicase as Treatment or Prevention of Hyperuricemia Associated With Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumor MalignancyCompletedNCT00230217Phase 4
- Safety and Pharmacokinetics of XL647 Administered Orally to Subjects With Solid TumorsCompletedNCT00086528Phase 1
- Safety/Efficacy of a Vaccine Prepared From Dendritic Cells Combined With Tumor Cells to Treat Advanced Kidney CancerCompletedNCT00050323Phase 1/2
- A Study of NM-3 Administered Orally in Patients With Advanced Solid Tumors.CompletedNCT00046696Phase 1